Avenue Therapeutics Inc (ATXI)
NASDAQ:ATXI
Holding ATXI?
Track your performance easily

Avenue Therapeutics (ATXI) Financial Statements

314 Followers

Avenue Therapeutics Financial Overview

Avenue Therapeutics's market cap is currently ―. The company's EPS TTM is $-7.414; its P/E ratio is -0.30; Avenue Therapeutics is scheduled to report earnings on March 25, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -2.52M$ 3.64M$ 617.00K$ 513.00K$ -4.02M
EBITDA$ -2.52M$ 3.64M$ 617.00K$ 513.00K$ -4.02M
Net Income Common Stockholders$ -7.19M$ -4.34M$ 640.00K$ 526.00K$ -4.01M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 4.92M$ 3.19M$ 1.78M$ 161.00K$ 1.57M
Total Assets$ 4.99M$ 3.31M$ 1.85M$ 502.00K$ 1.64M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -4.92M$ -3.19M$ -1.78M$ -161.00K$ -1.57M
Total Liabilities$ 1.16M$ 1.41M$ 1.20M$ 5.02M$ 7.76M
Stockholders Equity$ 4.76M$ 2.84M$ 1.58M$ -3.65M$ -5.34M
Cash Flow-
Free Cash Flow$ -2.25M$ -3.12M$ -2.32M$ -1.89M$ -4.67M
Operating Cash Flow$ -2.25M$ -3.12M$ -2.32M$ -889.00K$ -4.67M
Investing Cash Flow---$ -1.00M$ -2.00M
Financing Cash Flow$ 3.98M$ 4.53M$ 3.95M$ 479.00K-
Currency in USD

Avenue Therapeutics Earnings and Revenue History

Avenue Therapeutics Debt to Assets

Avenue Therapeutics Cash Flow

Avenue Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis